Delivery Order SPE2DB22D1106-SPE2DB25FFAE2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,247.04 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets (30-unit dose packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,574.00 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count units). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 23, 2025, and represents a non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $2,700.26 delivery order to AmerisourceBergen Drug Corp for 30 units of Clomid 50 mg tablets in unit-dose packaging. This firm fixed price, competitively awarded contract was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete...
- The Defense Logistics Agency awarded a $5,027.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Clomid 50 mg tablet unit dose packs (30 count). This is a non-set-aside contract with an ultimate completion date of July 21, 2025, and represents a standard pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $1,287.04 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, awarded on August 1, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.65 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30 count). The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed price delivery order with no set-aside designation. This award was competitively procured and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30s, with a ceiling value of $1,140.26. This is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements. The contract utilizes no set-aside designation and was competitively awarded through the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $5,757.54 and is structured as a firm fixed-price delivery order with an ultimate completion date of July 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $3,559.27 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.80 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 30 units. This firm fixed price delivery order, awarded July 24, 2025, with completion scheduled for July 25, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAE2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,176.82 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is scheduled for ultimate completion on July 29, 2025, with performance to be completed at the vendor's facility in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that supports global military healthcare programs. As a prime contractor to the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp supplies a wide range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company's federal procurement portfolio demonstrates extensive capability in delivering both brand-name and generic medications across multiple therapeutic domains through competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/28/25 |